Statement Of Changes In Equity [Abstract]

Biocartis Group NV - Filing #3122958

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	30,284,000 EUR	—	—	5,843,000 EUR	631,722,000 EUR	7,502,000 EUR	443,363,000 EUR	220,302,000 EUR	30,284,000 EUR	—	—	—	526,405,000 EUR	—	33,897,000 EUR	—	5,572,000 EUR	—	33,897,000 EUR	711,874,000 EUR	6,862,000 EUR	220,657,000 EUR	—	—	455,343,000 EUR	36,824,000 EUR	220,657,000 EUR	5,153,000 EUR	6,102,000 EUR	711,874,000 EUR	36,824,000 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	—	65,381,000 EUR	65,381,000 EUR	—	—	—	—	—	—	—	65,381,000 EUR	—	—	71,472,000 EUR	—	—	—	—	—	—	—	—	71,472,000 EUR	71,472,000 EUR	—	—	—	—	—	—	—
Comprehensive income	—	65,274,000 EUR	65,003,000 EUR	—	—	—	—	—	—	271,000 EUR	65,274,000 EUR	—	—	71,481,000 EUR	—	419,000 EUR	—	—	—	—	—	—	71,481,000 EUR	71,062,000 EUR	—	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	—	640,000 EUR	—	—	—	—	—	—	—	—	640,000 EUR	640,000 EUR	—	760,000 EUR	—	—	—	760,000 EUR	—	—	—	—	760,000 EUR	—	—	—	—	—	—	—	—